e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Mechanisms of exercise intolerance in cardiorespiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exercise pathophysiology in patients with pulmonary arterial hypertension
M. Schwaiblmair, T. Berghaus, C. Faul, W. von Scheidt (Augsburg, Germany)
Source:
Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Session:
Mechanisms of exercise intolerance in cardiorespiratory disease
Session type:
Electronic Poster Discussion
Number:
285
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Schwaiblmair, T. Berghaus, C. Faul, W. von Scheidt (Augsburg, Germany). Exercise pathophysiology in patients with pulmonary arterial hypertension. Eur Respir J 2007; 30: Suppl. 51, 285
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The definition of pulmonary hypertension: history, practical implications and current controversies
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010
Pulmonary rehabilitation in patients with pulmonary arterial hypertension
Source: ERS Course 2017
Year: 2017
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Exercise limitation in idiopathic pulmonary arterial hypertension (IPAH): there‘s more to it than just the pulmonary circulation
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005
Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
Functional impact of exercise pulmonary hypertension in patients with borderline pulmonary arterial pressure
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 393-398
Year: 2008
Pulmonary hypertension: pathophysiology and diagnosis
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007
Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Exercise-induced immune response in patients with idiopathic pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights
Year: 2015
Assessment of platelet dysfunction in patients with pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension
Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017
Year: 2017
Exercise training in pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 641s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept